author-photo

Linda L. Parker

National Institutes of Health

11

Papers

1330

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Isolation and Characterization of an HLA-DPB1*04: 01-restricted MAGE-A3 T-Cell Receptor for Cancer Immunotherapy.

2016 Journal of Immunotherapy
Show All
- Source
- Cite
- Save
Citations (20)
Abstract CT003: A phase I study of an HLA-DPB1*0401-restricted T-cell receptor targeting MAGE-A3 for patients with metastatic cancer

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
A Phase I study of an HLA-DPB1*0401-restricted T cell receptor targeting MAGE-A3 for patients with metastatic cancers

2015 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (4)
A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer

2006 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (864)
Large-Scale Depletion of CD25+ Regulatory T Cells from Patient Leukapheresis Samples

2005 Journal of Immunotherapy
Show All
- Source
- Cite
- Save
Citations (42)
Natural variation of the expression of HLA and endogenous antigen modulates CTL recognition in an In vitro melanoma model

1999 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (83)
T CELL-RECEPTOR V GENE USE BY CD4+ MELANOMA-REACTIVE CLONAL AND OLIGOCLONAL T-CELL LINES

1998 Journal of Immunotherapy
Show All
- Source
- Cite
- Save
Citations (6)
Growth of tumor-infiltrating lymphocytes from human solid cancers: Summary of a 5-year experience

1996 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (147)